Opinion

Video

Managing Chronic Postoperative Uveitis: Patient Case 1

Sunil Srivastava, MD, presents a case of a 68-year-old female with eye pain and decreased vision following complicated cataract surgery.

This is a video synopsis of a discussion involving Dr. Sunil Srivastava who is a uveitis and retina specialist at Cleveland Clinic. Dr. Srivastava presented two cases during the Ophthalmology Times®roundtable at the Academy.

The first case involves a 68-year-old female who underwent a complicated cataract surgery in her left eye, resulting in a three-piece sulcus eye well placement. After experiencing complications, including trephination and lensectomy, the patient developed cystoid macular edema (CME) and inflammation postoperatively. The round table discussion focused on the initial approach to postoperative CME. The consensus leaned towards topical therapy, specifically difluprednate, with some considering periocular steroids during eye well placement.

Despite initial improvement, the patient required an intravitreal triamcinolone injection to control cystoid macular edema. The challenge in using a dexamethasone implant in a patient with a sutured eye well was emphasized, as it could lead to migration issues into the anterior chamber. Eventually, the patient received an intravitreal fluocinolone acetonide implant after recurring cystoid macular edema.

The discussion touched on defining chronic CME, with most agreeing on a timeframe between three and six months or based on the number of required treatments. Dr. Srivastava expressed a personal preference for considering chronicity around the six-month mark, especially for patients requiring multiple treatment regimens.

Following the fluocinolone implant, the patient showed improvement, but ongoing monitoring revealed a potential increase in intraocular pressure (IOP). Management included topical antihypertensive medication, ensuring careful observation for pressure-related complications. The patient demonstrated sustained improvement over a three-year follow-up, maintaining normal IOP and visual acuity at 20/32. This case illustrates the challenges in managing cystoid macular edema post-complicated cataract surgery and highlights the efficacy of long-term treatment with the fluocinolone implant.

Video synopsis is AI-generated and reviewed by Ophthalmology Times® editorial staff.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.